The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases

pTau217: Clinical and Economic Benefits to the Healthcare System

In this episode, Dr. Soeren Mattke, physician and health services researcher at the University of Southern California, explores the growing role of blood-based biomarkers

Neuropathology in the Biomarker Age & Sleep in Lewy Body Disease, AD/PD™ Session Spotlight

In this episode, we spotlight Plenary Lectures 01 and 02 from the AD/PD™ 2026 International Conference, held on March 17, 2026. The lectures were chaired by Sandra O. Moo

Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Big Pharma, or Academia? AD/PD™ Session Spotlight

In this episode, we will cover the Fireside Debate "Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Big Pharma, or Academia?" tha

Drug Development & Biomarkers in Rare CNS Diseases, AD/PD™ Session Spotlight

In this episode, we spotlight Forum Discussion 08 from the AD/PD™ 2025 International Conference — “Drug Development & Biomarkers in Rare CNS Diseases (ALS, FTD) from Basi

Challenges and Opportunities for Anti-Tau Therapies: Turning Hope Into Clinical Progress, AD/PD™ Session Spotlight

In this episode, we highlight Forum Discussion 07 from the AD/PD™ 2025 International Conference — “Challenges and Opportunities for Anti-Tau Therapies in Clinical Trials

Therapy for AD, PD & LBD: Translational Models, Neuroinflammation, and Novel Therapeutic Targets, AD/PD™ Session Spotlight

In this episode, we spotlight Forum Discussion 06 from the AD/PD™ 2025 International Conference — “Therapy for AD, PD & LBD: Novel Translational Models, New Receptor- and

Pivotal Points in Prevention Trials and the New Era of Precision Medicine for Alzheimer’s Disease, AD/PD™ Session Spotlight

In this episode, we spotlight Plenary Lecture 06 from the AD/PD™ 2025 International Conference — “Pivotal Points in Prevention Trials and the New Era of Precision Medicin

Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies, AD/PD™ Session Spotlight

In this episode, we spotlight Forum Discussion 5 from the AD/PD™ 2025 International Conference — “Novel Approaches to Accelerate Development of Biomarkers, Imaging, and T

Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developments, AD/PD™ Session Spotlight

In this episode, we highlight Plenary Lecture 05 from the AD/PD™ 2025 International Conference — “Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developmen

Translational Drug Development in AD: Promising Strategies for Treatment and Disease Modification, AD/PD™ Session Spotlight

In this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™ 2025 International Conference — “Translational Drug Development in AD (Phase I–III) and

Treatment of DLB and PDD: Status and New Developments, AD/PD™ Session Spotlight

In this episode, we feature Plenary Lecture 04 from the AD/PD™ 2025 International Conference — the Eric N. Birch Memorial Lecture, titled “Treatment of DLB and PDD: Statu

Improving the Therapeutic Potential of Immunotherapies in Alzheimer’s Disease, AD/PD™ Session Spotlight

In this episode, we spotlight Forum Discussion 03 from the AD/PD™ 2025 International Conference: “Improving the Therapeutic Potential of Immunotherapies in AD – Can Novel

GLP-1R Agonist Effects in the Brain: Exploring Semaglutide and Neuroinflammation, AD/PD™ Session Spotlight

In this episode, we explore Plenary Lecture 2 from the AD/PD™ 2025 International Conference: “GLP-1R Agonist Effects in Brain.” Moderated by Dr. Cynthia Lemere (USA) and

Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and AI in MCI & AD, AD/PD™ Session Spotlight

In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — Forum Discussion 2, "Integrating Blood-Based,

The Alzheimer's Disease Drug Development Pipeline: Observations and Implications, AD/PD™ Session Spotlight

In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ 2025, titled "The Alzheimer's Disease Drug Development Pipeline: Observations and Im

Plasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies, AD/PD™ Session Spotlight

In episode 2 of AD/PD™ Session Spotlight, we feature Plenary Lecture 3, the Don Price Memorial Lecture, titled "Plasma Biomarkers for Dementias in the Era of Disease-Modi

Varying Regulatory Philosophies and AD Approval Priorities, AD/PD™ Session Spotlight

In this episode of AD/PD™ Session Spotlight, we delve into Forum Discussion 1, "Varying Regulatory Philosophies and AD Approval Priorities – USA, EU, Asia, and Other Part

Welcome to the AD/PD™ Session Spotlight

Welcome to AD/PD™ Session Spotlight, an official podcast series by AD/PD™. The podcast will discuss the latest cutting-edge science and real-world clinical impact in Alzh